18F-Choline Versus 68Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

18F-Choline Versus 68Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma

Published:2023-02-01 Issue:4 Volume:48 Page:e178-e180
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Urso Luca,Rocca Giovanni Christian¹,Uccelli Licia²,Ippolito Carmelo¹,Bartolomei Mirco³

Affiliation:

1. Urology Unit, Surgical Department, University Hospital of Ferrara, Ferrara, Italy

2. Translational Medicine Department, Ferrara University, Ferrara, Italy

3. Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, Ferrara, Italy

Abstract

Abstract Few articles in literature describe the potential usefulness of 18F-choline PET/CT and particularly 68Ga-PSMA-11 PET/CT in imaging of clear cell renal cell carcinoma (ccRCC). We report a unique comparison in literature between the 2 radiotracers in a patient who underwent left nephrectomy with diagnosis of ccRCC, grade 3. 68Ga-PSMA-11 PET/CT confirmed its emerging role in imaging ccRCC, as the incidentally detected renal neoplasm showed a significant higher uptake in comparison to 18F-choline PET/CT, inducing surgical indication.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference20 articles.

1. Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression;EJNMMI Res,2017

2. Role of PSMA-ligands imaging in renal cell carcinoma management: current status and future perspectives;J Cancer Res Clin Oncol,2022

3. The role of radiolabeled prostate-specific membrane antigen positron emission tomography/computed tomography for the evaluation of renal cancer;Eur Urol Focus,2020

4. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT;Ann Nucl Med,2015

5. 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results;Eur J Nucl Med Mol Imaging,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma – Today’s impact, tomorrow’s potential;Expert Review of Medical Devices;2023-12-12

2. 68Ga-LNC-1007 PET/CT Imaging in a Patient With Renal Cell Carcinoma Compared With 68Ga-PSMA-11 PET/CT;Clinical Nuclear Medicine;2023-10-07

3. 68Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade Tumors;Nuclear Medicine and Molecular Imaging;2023-04-24